Journal ArticleOPEN ACCESS

Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2

  • Lustig Y
  • Nemet I
  • Kliker L
  • et al.
New England Journal of Medicine (2021) 384(25) 2453-2454
DOI: 10.1056/nejmc2104036
55Citations
Citations of this article
88Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Vaccination after SARS-CoV-2 Infection Six patients previously infected with the original SARS-CoV-2 virus received the BNT162b2 vaccine. Before vaccination, they had neutralizing activity against ...

Cite

CITATION STYLE

APA

Lustig, Y., Nemet, I., Kliker, L., Zuckerman, N., Yishai, R., Alroy-Preis, S., … Mandelboim, M. (2021). Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2. New England Journal of Medicine, 384(25), 2453–2454. https://doi.org/10.1056/nejmc2104036

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free